Valneva Se News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Valneva se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Valneva Se Today - Breaking & Trending Today
By Stephen Nakrosis The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva. ....
By Andrea Figueras Valneva reported a narrowed loss for the first half, thanks to sharply reduced costs that offset a decline in revenue due to the effects. ....
Valneva SE (VALN), a specialty vaccine company, on Thursday reported a lower loss for the first half of the year compared to the same period last year. The company also confirmed its revenue guidance for the full year. ....
By Cecilia Butini Valneva has received positive safety data in a Phase 3 trial studying a vaccine against the mosquito-borne chikungunya virus. Data showed. ....
About two weeks after chikungunya virus (CHIKV) vaccine contender Bavarian Nordic A/S provided phase III data with its prospect, rival Valneva SE rolled out positive phase III safety findings in adolescents with its single-dose candidate VLA-1553. Results from the Saint-Herblain, France-based company’s first trial in an endemic area with people previously infected with CHIKV showed the product was generally safe and well-tolerated in subjects aged 12-17 years, regardless of previous infection by the mosquito-borne disease, carried mainly by Aedes aegypti and Aedes albopictus. Immunogenicity data from the study are expected in November. ....